This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovations of Phillip Anthony Hopes
Introduction
Phillip Anthony Hopes is a notable inventor based in Bristol, GB. He has made significant contributions to the field of chemistry, particularly in the development of compounds that activate glucokinase. His work is essential for advancing medical research and pharmaceutical applications.
Latest Patents
Phillip holds a patent for a chemical process for the preparation of an amido-phenoxybenzoic acid compound. This process is described as a method for making a compound of formula (I), which serves as an intermediate to compounds that activate glucokinase. His innovative approach is crucial for the development of new therapeutic agents.
Career Highlights
Phillip is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role involves research and development, where he applies his expertise in chemistry to create impactful solutions in healthcare. His dedication to innovation has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Phillip has collaborated with esteemed colleagues, including Jeremy Stephen Parker and Bharti Patel. These partnerships enhance the research environment and foster the exchange of ideas, leading to groundbreaking advancements in their field.
Conclusion
Phillip Anthony Hopes exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to influence the development of important medical compounds. His work is a testament to the impact of dedicated inventors in advancing science and healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
